Evidence map›Paper›PMID 24888687›Full record

ArticleJournal of dermatological science2014

Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development.

Pi-Ling Chang, Yu-Hua Hsieh, Chao-Cheng Wang, M Margaret Juliana, Yuko Tsuruta, Laura Timares, Craig Elmets, Kang-Jey Ho

Open access · greenAbstract read
In one paragraph

Article in Journal of dermatological science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Pi-Ling ChangDepartment of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: plchang@uab.edu.
Yu-Hua HsiehDepartment of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.
Chao-Cheng WangDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
M Margaret JulianaDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Yuko TsurutaDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Laura TimaresDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Craig ElmetsDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
Kang-Jey HoDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
University of Alabama at Birmingham · US

Funding

UAB Skin Diseases Research CenterP30AR050948 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ELMETS, CRAIG A · 2004 to 2013
$5.5M
Role of Osteopontin in Tumor PromotionR01CA090920 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHANG, PI-LING · 2002 to 2005
$1.1M
Osteopontin and microenvironment of initiated cellsR01CA137091 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHANG, PI-LING · 2009 to 2010
$591k
NCI NIH HHS R01 CA090920NCI NIH HHS R01 CA137091NCI NIH HHS R01 CA90920NIAMS NIH HHS P30 AR050948NIAMS NIH HHS P30 AR050948-05-9001
6 · The paper itself

Abstract

backgroundOsteopontin (OPN) is a matricellular glycoprotein that is markedly expressed in cutaneous squamous cell carcinomas (cSCCs) and in actinic keratoses implicating its role in photocarcinogenesis.

objectiveTo determine whether OPN facilitates the development of cSCC and its function.

methodscSCCs development was compared between wild-type (WT) and OPN-null mice subjected to UVB irradiation for 43 weeks. UVB-induced OPN expression was determined by Western blot, immunoprecipitation, ELISA, and semi-quantitative RT-PCR. Epidermal layer and TUNEL analyses assessed if OPN mediates UVB-induced epidermal hyperplasia or suppresses UVB-induced apoptosis of basal keratinocytes, respectively. In vitro experiments determined whether OPN enhances cell survival of UVB-induced apoptosis and its potential mechanisms. Immunohistochemical analyses of epidermis assessed the expression of CD44 and focal adhesion kinase (FAK), molecules that mediate OPN survival function.

resultsCompared to female WT mice, OPN-null mice did not develop cSCCs. UVB irradiation stimulated OPN protein expression in the dorsal skin by 11h and remains high at 24-48h. OPN did not mediate UVB-induced epidermal hyperplasia; instead, it protected basal keratinocytes from undergoing apoptosis upon UVB exposure. Likewise, the addition of OPN suppressed UVB-induced OPN-null cSCC cell apoptosis, the activation of caspase-9 activity, and increased phosphorylation of FAK at Y397. Furthermore, the expression of CD44 and FAK in WT mice epidermis was greater than that of OPN-null mice prior to and during early acute UVB exposure.

conclusionThese data support the hypothesis that chronic UVB-induced OPN expression protects the survival of initiated basal keratinocytes and, consequently, facilitates cSCC develop.

Indexed as

AnimalsApoptosisCarcinoma, Squamous CellCell LineCell SurvivalCell Transformation, NeoplasticDisease Models, AnimalEpidermisFemaleFocal Adhesion Kinase 1Gene Expression RegulationHyaluronan ReceptorsHyperplasiaKeratinocytesMice, 129 StrainMice, KnockoutCd44 protein, mouseFocal Adhesion Kinase 1Hyaluronan ReceptorsOsteopontinPtk2 protein, mouseSpp1 protein, mouse

Identifiers

PMID24888687
PMCPMC4128184
OpenAlexW2006028933

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.